3M applies science in collaborative ways to improve lives daily. With $32 billion in sales, the company’s 96,000 employees connect with customers all around the world. 3M invests about 6 percent of its sales into research and development – an investment that helps produce more than 3,000 patents each year. 3M owns 51 technology platforms, which range from adhesives and abrasives, to ceramics and nanotechnology. 3M's more than 8,500 scientists around the world share and combine these technologies across all its businesses to create a steady stream of unique products for customers.

3M is helping the world respond to COVID-19 at a time when the pandemic has created unprecedented demand for critical products. During this global crisis, the safety of our employees and the public, including health care workers and first responders fighting COVID-19, is our highest priority. We are making more respirators than ever before. Since January, we have doubled global N95 respirator production and are on track to increase our capacity to produce N95 and other respirators to 2 billion per year globally by the end of 2020.